Vermont Lawmakers Send Legislation to Regulate Cannabis Sales to Governor, Illinois Gives Dispensary Applicants Another Shot at Licensing Lottery: Week in Review
[PRESS RELEASE] Tropizen announced on Sept. 1 the completion of its first commercial cannabis harvest grown in its recently added 10,000 square foot outdoor cultivation facilities. The new harvest, destined for both flower sales and the manufacture of infused medicinal products, arrives as patient demand for cannabis flower in Puerto Rico continues to surpass available market supply.
“This harvest represents an important milestone for our company as we continue to expand to meet patient demand for high-quality flower,” said Tropizen co-founder Marni Meistrell. “We are growing cannabis near the base of El Yunque tropical rainforest, following cultivation best practices as we conduct research and test new strains that thrive in this location.”
An additional 7,000 square feet of outdoor cultivation will be added before the end of the year, according to Meistrell. Tropizen recently expanded its cannabis flower production to 400% of original capacity, at an investment of over $1 million. The expansion project included the construction of the new outdoor cultivation space.
READ MORE: Tropizen Finds Success in Puerto Rico’s Cannabis Market
The new harvest is comprised of five of the company’s best performing strains. Tropizen rotates 50 primary strains with 5 secondary strains, including Brian Berry Cough, Ogiesel and Agent Orange, all exclusive to Tropizen in Puerto Rico. One of the company’s priorities going forward is the cropping of rare tropical cultivars as part of its ongoing research and development process.
Meistrell said the company is working on the introduction of a new packaging and grading system for its cannabis flower, incorporating a new pre-packaged midgrade flower product that will be more accessible to patients in terms of price, while offering the same effectiveness as the premium flower.
Tropizen was the first cannabis cultivator in the island to offer individually pre-packaged flower to dispensaries instead of bulk cannabis packaging. The former facilitates higher sales volumes for dispensaries. Moreover, patients get a fresher product, as the packaging protects the delicate cannabis flower from exposure to degrading environmental conditions, including oxygen and moisture. Presently, prepackaged flower comprises approximately 20% of the company’s sales to dispensaries.
With lab-tested cannabinoid concentrations of over 20% (and as high as 30%), Tropizen offers product consistency, exceptional plant genetics and attention to detail, according to Novacann Labs Director of Operations Christian Burgos. “Normally we see that quality suffers when production volume increases, however, this has not been our experience with Tropizen. The results from their harvest evidence strict compliance and consistent quality control,” explained Burgos.
As part of its cultivation protocol, Tropizen uses live soil with beneficial insects in its outdoors cultivation facilities, as well as organic processes. An outside entomologist serves as technical advisor and conducts weekly inspections of the plants. Moreover, chemical pesticides are not used.
Meistrell noted that cannabis flower has been in short supply in Puerto Rico this summer. “Dispensaries are consistently running out of product even though our volume has increased. We seem to be approaching a worrisome scenario where patients have a harder time acquiring their medicine, driving prices up.” The growth in patient numbers may be a contributing factor but official figures have not been published so far this year.
Published at Sat, 26 Sep 2020 12:30:00 +0000